Anogenital cancers testing in Maiori

Find health labs to test for Anogenital cancers in Maiori and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Synlab

Via Gaetano Capone, 31, 84010 Maiori SA, Italia

Unverified

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Laboratorio Lifebrain

Via Garofalo Maggiore, 14 84010 Minori (SA)

0.8 km

Unverified

See Details

Pap Smear by Biocava Analisi Cliniche

Corso Principe Amedeo, 3, 84013 Cava de' Tirreni SA, Italia

4.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Nicola Bruni Grimaldi, 95 84014 Nocera Inferiore (Salerno) (SA)

6.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Federico Ricco, 24 84014 Nocera Inferiore (SA)

6.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Domenico Cicalesi, 95 84014 Nocera Inferiore (SA)

6.4 km

Unverified

See Details

Pap Smear by Synlab

Via Mangioni, 19, 84016 Pagani SA, Italia

6.3 km

Unverified

See Details

Pap Smear by Laboratorio Analisi Cliniche Gentile s.a.s.

Via Vittorio Veneto 169, 80054 Gragnano Naples, Italy

6.9 km

Verified

See Details

Pap Smear by Synlab

Viale Antonio Gramsci, 75, 84126 Salerno SA, Italia

6.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Cesare Battisti, 7 84010 San Marzano sul Sarno (SA)

9 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Roma 35 80059 Torre del Greco (Napoli)

17.3 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.